"Navigating the Modern News Zoo so you don't have to."
Saturday, April 19, 2025
Study finds women much more likely to be aware of and have good understanding of obesity drugs
New research being presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11–14 May) shows that women are much more aware of and knowledgeable about the obesity drugs GLP-1/GIP receptor agonists (that include semaglutide and tirzepatide).
White Hulk Squares up to 5 Cops During DUI Stop THEN THIS HAPPENS!
- On Iran, Nuclear Dismantlement Must Be the Goal - The Editors
- Unraveling the Mysteries of Black Holes and Entropy - Arya Chandran
- McDonald's teases the return of a fan favorite item after nearly 10 years
- Best Dental Insurance Plans of 2025
- World’s Best Investment Banks 2025: Global And Country Winners - Thomas Monteiro
- The Innovative Approach to Track Small Space Debris - Arya Chandran
This PowerBank Never Dies!
- Russia Eyes Pacific Air Base on Doorstep of US Ally: Report - Diana Zapata
- Minecraft soundtrack among 'defining sounds of history' added to Library of Congress
- Is the Rash Around Your Child’s Mouth From a Food Allergy? What To Know - Wendy Wisner
- ChatGPT Experiences Outage Amid OpenAI's Internal Turmoil - Michael Terry
- US has 800 measles cases and outbreaks in several states. Here's what you should know
- To Save Medicaid, We Have to Cut It - Sally C. Pipes
